Monocyte-to-HDL-Cholesterol ratio independently tied to all-cause and CV mortality in CAD

Written by Dr Aditi Yadav Published On 2022-12-25T20:00:07+05:30 | Updated On 25 Dec 2022 8:00 PM IST

China: A study published in the Lipids in Health and Disease, BMC has concluded that the Elevated monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) in the general population is independently related to all-cause and cardiovascular mortality.

Elevated MHR value is related to higher all-cause and cardiovascular mortality in coronary artery disease patients and other comorbidities. MHR could predict cardiovascular events in chronic kidney disease. However, there needs to be more data about the general population. There is a lack of data concerning MHR's prognostic value for long-term mortality in the general population.

This study investigated MHR association with all-cause and cardiovascular mortality in the United States adult population.

Considering this, a study was conducted to investigate,

Based on data from NHANES 1999-2014 for the adult US population, What is the clinical significance of MHR in predicting all-cause and cardiovascular mortality?

The lead researcher was Dr Ming Jiang from the Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

The study methods and results could be summarised as follows:

The study included 34,335 participants aged≥20 years.
Kaplan-Meier plots, long-rank tests, multivariate Cox regression and restricted cubic spline analysis, were used in the study.
The average follow-up duration was of 93.5 ± 56 months.
Four thousand three hundred ten participants constituting 12.6%, died.
Seven hundred fifty-four participants constituting 2.2% of deaths, were attributed to cardiovascular diseases.
There were statistically significant differences in all-cause and cardiovascular mortality among the MHR tertiles (log-rank test: all P < 0.001).
The participants in the highest tertile of MHR had an increased risk of all-cause and cardiovascular mortality with a hazard ratio of 1.19 and 1.44, respectively, compared to the lowest tertile.
MHR had a non-linear association with all-cause mortality, which was significant, and the inflection point was 0.006.
Each 2-fold change in MHR was related to a 32% decrease and a 20% increase with HR of 0.68 and 1.20, respectively, in the risk of all-cause mortality on the left and right flanks of the inflection point respectively.
Every 2-fold change in MHR was associated with increased cardiovascular mortality by 21 % with an HR of 1.21.

The study has suggested that MHR is a promising predictor for identifying individuals with a higher risk of poor clinical outcomes.

The researchers also mentioned that MHR is inexpensively acquired. Hence, it is a convenient clinical tool for risk stratification. It also guides the strategies for both preventative and treatment for clinicians, which could be applied in routine clinical care.